ImageneBio, Inc. (IMA)
NASDAQ: IMA · Real-Time Price · USD
4.240
-0.020 (-0.47%)
At close: Oct 9, 2026, 4:00 PM EDT
4.250
+0.010 (0.24%)
After-hours: Oct 9, 2026, 4:00 PM EDT
ImageneBio Market Cap
ImageneBio has a market cap or net worth of $48.13 million as of October 9, 2026. It is the 30,717th most valuable company in the world and the 4,702nd biggest in the United States. Its market cap has decreased by 47.95% in one year.
Market Cap
48.13M
Enterprise Value
-86.11M
1-Year Change
-47.95%
Global Rank
Country Rank
#4,702 United States
Category
ChartMarket Cap Chart
Since July 28, 2025, ImageneBio's market cap has decreased from $183.04M to $48.13M, a decrease of -73.71%. That is a compound annual growth rate of -67.15%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2026 | 48.13M | -37.62% |
| Dec 31, 2025 | 77.15M | -57.85% |
| Jul 28, 2025 | 183.04M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Celularity | 50.62M |
| Elicio Therapeutics | 49.67M |
| Caribou Biosciences | 49.34M |
| eXoZymes | 48.73M |
| CervoMed | 48.68M |
| Werewolf Therapeutics | 47.61M |
| Dogwood Therapeutics | 47.59M |
| Edesa Biotech | 47.43M |